The Scandinavian Sarcoma Group—background, organization and the SSG Register—the first 25 years

References

• Alho A, Alvegird T A, Berlin 0, Ranstam J, Rydholm A, Rooser B, Stener B for the Scandinavian Sarcoma Group. Surgical margin in soft tissue sarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand 1989; 60(6): 687–92.
   Google Scholar
• Alvegfird T A, Solheim 0, Elomaa I. Ewing's sarcoma — a preliminary report from the Scandinavian Sarcoma Group. Acta Oncol 1989 (Suppl 2); 28: 59–64.
   Google Scholar
• Alvegfird T A. Management and prognosis of patients with high-grade soft tissue sarcomas. An evaluation of a Scan-dinavian joint care program. University of Lund (thesis), (1989) Lund.
   Google Scholar
• Alvegfird T A, Sigurdsson H, Mouridsen H, Solheim 0, Unsgaard B, Ringborg U, Dahl 0, Nordentoft A M, Blomqvist C, Rydholm A, Stener B, Ranstam J. Adjuvant chemotherapy with Doxorubicin in high-grade soft tissue sarcoma: A randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol 1989; 7: 1504–13.
   Google Scholar
• Alvegfird T A, Berg N 0. Histopathology peer review of high-grade soft tissue sarcoma. The Scandinavian Sar-coma Group experience. J Clin Oncol 1989; 7: 1845–51.
   Google Scholar
• Alvegfird TA, Berg NO, Ranstam J, Rydholm A, Miser B. Prognosis in high-grade soft tissue sarcomas. The Scan-dinavian Sarcoma Group experience in a randomized adjuvant chemotherapy trial. Acta Orthop Scand 1989; 60(5): 517–21.
   Google Scholar
• Alvegfird TA, Berg N 0, Baldetorp B, Ferno M, KillanderD, Ranstam J, Rydholm A, Akerman M. Cellular DNA content and prognosis of high grade soft tissue sarcoma. The Scandinavian Sarcoma Group experience. J Chin Oncol 1990; 8: 538–47.
   Google Scholar
• Alvegfird T A. List of publications from the Scandinavian Sarcoma Centers. Scandinavian Sarcoma secretariat. 1994; 125: 1989–93.
   Google Scholar
• Bacci G, Ferrari S, Longhi A, Picci P, Mercuri M, Alvegard TA, Saeter G, Conati D, Manfrini M, Lan S, Briccoli A, Forth C. High Dose Ifosfamide in Combination with High Dose Methotrexate, Adriamycin and Cisplatin in the Neo-adjuvant Treatment of Extremity Osteosarcoma: Prelimi-nary Results of an Italian Sarcoma Group/Scandinavian Sarcoma Pilot Study. J Chemoth 2002; 14(2): 198–206.
   PubMed Web of Science ®Google Scholar
• Bauer HCF, Alvegird TA, Berlin 0, Erlanson M, Kalen, A, Lindholm P, Gustafson P, Smeland S, Trovik CS. The Scandinavian sarcoma register 1986–2002. Acta Orthop Scand 2004; (Suppl 311): 8–10.
   Google Scholar
• Bauer HCF, Moller T, Alvegird TA, Rydholm A, Gustafson P, Solheim O, Erlanson M, Karlsson M, Monge 0, Trovik
   Google Scholar
• C, Blomqvist C, Wiklund T, Berlin 0, Turesson I. Moni-toring referral and treatment in soft tissue sarcoma: Study based on 1851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2001; 72:150–9.
   Google Scholar
• Elomaa I, Blomqvist C, Saeter G, Nilbert M, Monge 0, Wiebe T, Alvegfird T A. Chemotherapy in Ewing's sar-coma—the Scandinavian Sarcoma Group experience. Acta Orthop Scand 1999; Suppl 285: 69–73.
   Google Scholar
• Elomaa I, Blomqvist C, Saeter G, Akerman M, Stenwig
   Google Scholar
• E, Wiebe T, Björk 0, Alvegird TA. Five-year results in Ewing's sarcoma. The the Scandinavian Sarcoma Group experience with the SSG XI protocol. Eur J Cancer 2000; 36: 875–80.
   Google Scholar
• Gustafson P. Soft tissue sarcoma. Epidemiology and prog-nosis in 508 patients. Acta Orthop Scand 1994; 65 (Suppl 259): 131.
   Google Scholar
• Gustafson P, Akerman M, Alvegird T A, Coindre J M, Fletcher C D M, Rydholm A, Will& H. Prognostic infor-mation in soft tissue sarcoma using tumour size, vascular invasion, and microscopic tumour necrosis — the SIN-system. Eur J Cancer 2003; 39: 1568–76.
   Google Scholar
• Hansen BH, Wedin R, Keller J, Laitinen M, Berg P, Skjeldal S, Trovik C, Nilsson J, Walloe A, Kalen A. The Scandi-navian sarcoma group skeletal metastasis register. Sur-vival after surgery for bone metastases in the pelvis and extremities. Acta Ortop Scand 2004 (in press).
   Google Scholar
• Nilbert M, Saeter G, Elomaa I, Monge 0, Wiebe T, Alvegird T. Ewing's sarcoma treatment in Scandinavia 1984–1990. Acta Oncol 1998; 37(4); 375–78.
   Google Scholar
• Rydholm A. Management of patients with soft—tissue tumors. Strategy developed at a regional oncology center. Acta Orthop Scand 1983; (Suppl 203): 54.
   Google Scholar
• Rydholm A. Centralization of soft tissue sarcoma. The southern Sweden experience. Acta Orthop Scand 1997; 68 (Suppl 273) : 4–8.
   Google Scholar
• Rydholm A, Alvegird T. Scandinavian Sarcoma Group, Goteborg, Sweden, May 5-7, 1993. Acta Orthop Scand 1994a; 65 (Suppl 265): 55–72.
   PubMedGoogle Scholar
• Rydholm A, Alvegird T A. Scandinavian Sarcoma Group, Helsinki, April 10-22, 1994. Acta Orthop Scand 1994b;65 (Suppl 262): 63–80.
   Google Scholar
• Rydholm A, Alvegird T A. Scandinavian Sarcoma Group, Stockholm, April 26-28, 1995. Acta Orthop Scand 1995;66 (Suppl 265): 89–100.
   Google Scholar
• Rydholm A, Alvegird T A. Scandinavian Sarcoma Group, Reykjavik, May 7-9, 1996. Acta Orthop Scand 1996; 67 (Suppl 272): 41–59.
   Google Scholar
• Rydholm A, Alvegird T A. Scandinavian Sarcoma Group, Trondheim, April 16-18, 1997. Acta Orthop Scand 1997; 68 (Suppl 274): 65–77.
   Google Scholar
• Rydholm A, Alvegird T A. Scandinavian Sarcoma Group, Snekkersten, April 22-24, 1998. Acta Orthop Scand 1998; 69 (Suppl 282): 25–43.
   PubMedGoogle Scholar
• Smeland S, Muller C, Alvegird TA, Wiklund T, Wiebe T, Björk 0, Stenwig AE, Willén H, Holmstrom T, Follerfis G, Brosjö 0, Kivioja A, Jonsson K, Monge 0, Saeter G. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 2003; 39: 488–94.
   Google Scholar
• Smeland S, Wiebe T, Brosjö 0, Bohling T, Alvegird TA. Chemotherapy in Ewing's sarcoma — The Scandinavian Sarcoma Group experience. Acta Orthop Scand 2004;
   Google Scholar
• Solheim 0, Alvegird T A, Elomaa I. Adjuvant chemo-therapy for osteosarcoma a preliminary report from the Scandinavian Sarcoma Group. Acta Oncol 1989 (Suppl 2); 28: 53–7.
   Google Scholar
• Solheim 0, Alvegird T A. The Scandinavian Sarcoma Group. 10 Years' experience. Acta Oncol 1989 (Suppl 2); 28: 175.
   Google Scholar
• Solheim 0, Saeter G, Elomaa I, Alvegird T A. The treat-ment of osteosarcoma: Present trends. The Scandinavian Sarcoma Group experience. Annals of Oncology 1992 (Suppl 2); 3: 711.
   Google Scholar
• Saeter G, Alvegfird TA, Elomaa I, Stenwig E, Holmstrom T, Solheim 0. Treatment of osteosarcoma of the extremities with the T10 protocol, with emphasis on the effects of preoperative chemotherapy with single agent high—dose methotrexate. A Scandinavian Sarcoma Group study. J Clin Oncol 1991; 9: 1766–75.
   Google Scholar
• Saeter G, Strander H, Monge 0 R, Alvegfird T A. Dose escalating etoposide (E), ifosfamide (I) and granulocyte colony stimulating factor (GCSF) (VIGregimen) in advanced adult soft tissue sarcoma. A Scandinavian Sar-coma Group study. Ann Oncol 1994 (5 suppl); 8: 171.
   Google Scholar
• Saeter G, Talle K, Solheim 0. Treatment of advanced, high—grade soft—tissue sarcoma with ifosfamide and continuos infusion etoposide. Cancer Chemotherapy and Pharmacology 1995; 36: 172–5.
   Google Scholar
• Saeter G, Alvegird T A, Monge 0, Strander H, Turesson I, Klepp R, Soderberg M, Wist E, Raabe N, Erlanson M, Solheim 0, Hannisdal E. Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study. Eur J Cancer 1997;33(10):1551–8
   Google Scholar
• Saeter G for the Scandinavian Sarcoma Group. Treatment of osteosarcoma with high—dose methotrexate containing neoadjuvant chemotherapy. Scandinavian Sarcoma Group data. Med Ped Oncol 1996a; 27(4): 263.
   Google Scholar
• Saeter G for the Scandinavian Sarcoma Group. Treatment strategies and outcome in metastatic (relapsed) osteo-genic sarcoma. The Scandinavian Sarcoma Group (SSG) experience. Med Ped Oncol 1996b; 27(4): 264.
   Google Scholar
• Tierney J F, Mosseri V, Stewart LA, Souhami R L, Parmar M K. Adjuvant chemotherapy for soft—tissue sarcoma: review and meta—analysis of the published results of ran-domized clinical trials. Br J Cancer 1995; 72: 469–75.
   Google Scholar
• Tierney J F. Adjuvant chemotherapy for localized resectable soft—tissue sarcoma of adults: meta—analysis of individual data. Sarcoma meta—analysis collaboration. Lancet 1997; Vol 350 No 9092, 1647–54.
   Google Scholar
• Wiklund T A, Alvegird T A, Mouridsen H T, Rydholm A, Blomqvist C P. Marginal surgery and postoperative radiotherapy in soft tissue sarcomas. Eur J Cancer 1993; 29A: 30–69.
   Google Scholar